Biblio Discovery — Demo Discovery Service

11 hasil untuk "Kieran Adam"

Menampilkan 1–11 · 0,17 detik · RSS

  1. Artikel Jurnal

    Immunohistochemistry of Immune Cells and Cells Bound to in vivo Administered Antibodies in Liver, Lung, Pancreas, and Colon of B6/lpr Mice

    Kieran Adam; Adam Mor

    Bio-Protocol, Vol. 12 No. 14 · 2022 · Inggris · DOAJ Scopus

    Employing a novel mouse model of immune related adverse events (irAEs) induced by combination of anti-PD1 and anti-CTLA-4 antibodies, we visualized immune infiltration into the liver, lung, pancreas, and colon. Here, we describe the avidin-biotin conjugate (ABC) method used to stain T cells (CD4…

  2. Artikel Jurnal

    Data on the identification of VRK2 as a mediator of PD-1 function

    Michael Peled; Kieran Adam; Adam Mor

    Data in Brief, Vol. 37 · 2021 · Inggris · DOAJ Scopus

    Therapeutic programmed cell death protein 1 (PD-1) blockade enhances T cell mediated anti-tumor immunity, but many patients do not respond, and a significant proportion develops inflammatory toxicities. To develop better therapeutics and to understand the signaling pathways downstream of PD-1 we…

  3. Artikel Jurnal Teks lengkap

    A novel mouse model for checkpoint inhibitor-induced adverse events.

    Kieran Adam; Alina Iuga; Anna S Tocheva dkk.

    PLoS ONE, Vol. 16 No. 2 · 2021 · Inggris · DOAJ Scopus

    Immune checkpoint inhibitors have demonstrated significant efficacy in the treatment of a variety of cancers, however their therapeutic potential is limited by abstruse immune related adverse events. Currently, no robust animal model exists of checkpoint inhibitor-induced adverse events…

    Juga tersedia di: PLOS

  4. Artikel Jurnal

    PD-1-stimulated T cell subsets are transcriptionally and functionally distinct

    Shalom Lerrer; Anna S. Tocheva; Shoiab Bukhari dkk.

    iScience, Vol. 24 No. 9 · 2021 · Inggris · DOAJ Scopus

    Summary: Despite the obvious inhibitory outcome of PD-1 signaling, an additional series of functions are activated. We have observed that T cells stimulated through the T cell receptor (TCR) and PD-1 primarily do not proliferate; however, there is a population of cells that proliferates more than…

  5. Artikel Jurnal

    Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells

    Marianne Strazza; Inbar Azoulay-Alfaguter; Michael Peled dkk.

    Communications Biology, Vol. 4 No. 1 · 2021 · Inggris · DOAJ Scopus

    Strazza et al. show that phosphoprotein associated with glycosphingolipidenriched microdomains 1 (PAG) is phosphorylated following PD-1 ligation. They find that PAG deletion sensitizes tumors to PD-1 blockade. This study suggests PAG as a critical mediator of PD-1 signaling and a promising target…

  6. Artikel Jurnal

    Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growth

    Marianne Strazza; Emily K. Moore; Kieran Adam dkk.

    Molecular Therapy: Methods & Clinical Development, Vol. 27 · 2022 · Inggris · DOAJ

    The transmembrane adaptor phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG) is phosphorylated in T cells downstream of PD-1 signaling and contributes to the resulting functional inhibition of multiple cellular processes. Furthermore, PAG expression is negatively…

  7. Artikel Jurnal Teks lengkap

    SLAMF6 clustering is required to augment T cell activation.

    Matthew A Dragovich; Kieran Adam; Marianne Strazza dkk.

    PLoS ONE, Vol. 14 No. 6 · 2019 · Inggris · DOAJ Scopus

    The signaling lymphocytic activation molecule (SLAM) family is comprised of nine distinct receptors that are expressed exclusively on hematopoietic cells. Most of these transmembrane receptors are homotypic by nature and downstream signaling occurs when cells that express the same SLAM receptor…

    Juga tersedia di: PLOS

  8. Artikel Jurnal

    SLAMF6 compartmentalization enhances T cell functions

    Yevgeniya Gartshteyn; Anca D Askanase; Ruijiang Song dkk.

    Life Science Alliance, Vol. 6 No. 2 · 2023 · Inggris · DOAJ Scopus

    After stimulation, the T cell co-receptor SLAMF6 colocalizes with the TCR–CD3 complex to enhance T cell activation. Targeting SLAMF6 localization and function with bispecific antibodies is a novel mechanism with potential therapeutic translation. Signaling lymphocyte activation molecule family…

  9. Artikel Jurnal

    Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity

    Brian S Henick; Xizi Hu; Shoiab M Bukhari dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 12 No. 3 · 2024 · Inggris · DOAJ Scopus

    Background Immune checkpoint inhibitors (ICIs) have improved outcomes and extended patient survival in several tumor types. However, ICIs often induce immune-related adverse events (irAEs) that warrant therapy cessation, thereby limiting the overall effectiveness of this class of therapeutic…